Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Besides Astria Therapeutics Inc. () shares, it purchased Verrica Pharmaceuticals stock last week (see below) and those of other several other biotechs throughout 2023.
Source: https://247wallst.com/investing/2023/12/31/heres-what-insiders-are-buying-to-wrap-up-the-year/
Boston Pinnacle Properties is joining the ranks of developers anticipating growth of Somerville’s Assembly Square life science cluster, with a focus on attracting early-stage biotechs.
Source: https://bankerandtradesman.com/lab-tower-proposed-in-assembly-point/
Pharmaceutical companies are often competing against each other for the most prized biotechs.
Shares trade for a reasonable 17 times earnings — a premium to slower-growing pharma companies, but well under valuations of high-growth biotechs.
Source: https://investorplace.com/2023/11/5-growth-stocks-to-buy-for-2024/
The company is an affiliate of ElevateBio, whose raison d’etre is to leverage its cell and gene therapy manufacturing capabilities into ownership interests of companies such as AlloVir – a sort of hedge fund hotel for biotechs.
To sum up, while risks are involved, Moderna is anticipated to remain one of the leading biotechs in 2028.
Source: https://investorplace.com/2023/05/the-3-most-talked-about-stocks-and-cryptos-right-now/
You may have also seen biotechs and biopharma stocks reward shareholders when acquired.